RecruitingNot ApplicableNCT05903196

Radiofrequency Ablation Study in LatinX Patients

Study of the Use of Radiofrequency Ablation in LatinX Patients With Symptomatic Benign Thyroid Nodules


Sponsor

Northwell Health

Enrollment

44 participants

Start Date

Mar 12, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Benign thyroid nodules can still create cosmetic, compressive, or hormonal issues for patients. In the past, surgery was typically used to treat thyroid nodules causing the above issues through partial or complete thyroidectomy. More recently, minimally-invasive techniques have been developed to treat these issues. This study is investigating the use of one of these techniques, radiofrequency ablation, in Latinx patients with benign symptomatic thyroid nodules. This procedure is of interest because it avoids the risks of surgery and can be done outside an operating room. The study hypothesis is that the use of RFA is an effective and safe therapeutic option for LatinX patients with a symptomatic benign nodule wishing to avoid surgery.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating radiofrequency ablation — a minimally invasive procedure that uses heat to shrink nodules — for benign (non-cancerous) thyroid nodules in LatinX patients, a group historically underrepresented in thyroid research. **You may be eligible if...** - You are 18 or older and self-identify as LatinX - You have a benign thyroid nodule that is causing symptoms (such as discomfort, difficulty swallowing, or visible swelling) - Your nodule has well-defined edges on ultrasound and is surrounded by at least 2mm of normal thyroid tissue in all directions **You may NOT be eligible if...** - You are pregnant, trying to become pregnant, or breastfeeding - You have a cardiac pacemaker, defibrillator, or other electrical medical devices - Your nodule is malignant or not predominantly solid (must be more than 50% solid) - You are on blood thinners or dual antiplatelet therapy - You have an acute illness or blood pressure above 140/90 before the scheduled procedure Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMygen V-1000 RF system

The Mygen V-1000, a microprocessor-based generator of RF Medical Co., Ltd., provides up to 140 watts of radio-frequency (RF) energy to be used for coagulation \& ablation of vessel, tissue \& bone


Locations(1)

Northwell Health Physician Partners

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05903196


Related Trials